Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Well CorpAMWL · Entity 2112 | Chief Technology Officer | February 01, 2023 | February 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Well Corp
Report date February 01, 2023 · Filed February 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 641,380 |
Reported balance
After 2023-02-01 transaction · row 1
1 source rowRow 1 · 2023-02-01 · Sale · Disposed 5,444 · Balance 641,380 F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on February 1, 2023. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on February 1, 2023. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2023 Filed Feb 3, 2023 22:16 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 5,444 | $3.88 | $21,146.13 |
DisclosureSEC source: 0001209191-23-007059 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,380 F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on February 1, 2023. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 15,903 | $3.72 | $59,162.34 |
DisclosureSEC source: 0001209191-22-059793 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646,824 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:36 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 4,813 | $3.99 | $19,215.42 |
DisclosureSEC source: 0001209191-22-055575 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,727 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on November 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:50 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 15,642 | $4.28 | $66,974.35 |
DisclosureSEC source: 0001209191-22-048922 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,540 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on September 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 21:47 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 4,896 | $4.03 | $19,706.89 |
DisclosureSEC source: 0001209191-22-044307 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,182 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on August 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 11:58 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 15,902 | $3.57 | $56,779.68 |
DisclosureSEC source: 0001209191-22-033777 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,078 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on June 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:44 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 19,575 | $3.58 | $70,060.88 |
DisclosureSEC source: 0001209191-22-025058 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,980 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on April 15, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:59 UTC | American Well Corp AMWL · Entity 2112 | GrantPerformance Share Units · Derivative | 232,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015785 · doc4.xml · derivative · entry 3 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,428 Underlying: Class A Common Stock · 232,428 shares Expires not disclosed F4 · derivative.exercise_price: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified. F4 · derivative.exercise_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified. F4 · derivative.expiration_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:59 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 232,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015785 · doc4.xml · nonDerivative · entry 2 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,555 F2 · shares: Represents a grant of restricted stock units, with 25% vesting upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining vesting every 3 months thereafter over a three-year period (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date). F3 · balance_after: Securities Beneficially Owned includes shares acquired pursuant to the Issuer's employee stock purchase plan in a transaction exempt under Rule 16b-3. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:59 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 17,893 | $3.94 | $70,491.26 |
DisclosureSEC source: 0001209191-22-015785 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,459 F1 · kind: The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on March 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:38 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 1,800 | $6.59 | $11,863.80 |
DisclosureSEC source: 0001209191-21-068863 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,352 F1 · date: The reporting person sold shares on December 1, 2021 (the "December 1 Sale"), pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2021, in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 1, 2021 (the "December 1 RSU Vest"). The December 1 Sale was not sufficient to cover the reporting person's entire tax liability arising from the December 1 RSU Vest. The sale reported in this Form 4 was made outside of a 10b5-1 plan in order to pay the remaining part of the reporting person's tax liability arising from the December 1 RSU Vest. F1 · kind: The reporting person sold shares on December 1, 2021 (the "December 1 Sale"), pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2021, in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 1, 2021 (the "December 1 RSU Vest"). The December 1 Sale was not sufficient to cover the reporting person's entire tax liability arising from the December 1 RSU Vest. The sale reported in this Form 4 was made outside of a 10b5-1 plan in order to pay the remaining part of the reporting person's tax liability arising from the December 1 RSU Vest. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:16 UTC | American Well Corp AMWL · Entity 2112 | SaleClass A Common Stock | 14,300 | $6.39 | $91,325.52 |
DisclosureSEC source: 0001209191-21-067907 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,152 F1 · date: The sale reported in this Form 4 was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2021, and was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 1, 2021. F1 · kind: The sale reported in this Form 4 was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2021, and was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 1, 2021. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 22:31 UTC | American Well Corp AMWL · Entity 2112 | Tax withholdingClass A Common Stock | 54,956 | $10.28 | $564,947.68 |
DisclosureSEC source: 0001209191-21-051680 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,452 Read SEC document |
| April 15, 2021 Filed Apr 27, 2021 21:21 UTC | American Well Corp AMWL · Entity 2112 | GrantClass A Common Stock | 135,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028616 · doc4.xml · nonDerivative · entry 1 Kutan Serkan · CIK 0001824268 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575,408 F1 · shares: Represents a grant of restricted stock units, with 25% vesting upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining vesting every 3 months thereafter over a three-year period (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.